Portfolio
LUMO Fund II
- Aiosyn
- Airhub
- AlphaBeats
- Autoscriber
- Beyond Weather
Aiosyn’s AI solutions empower pathologists to make their work more accurate, efficient and effective, for the benefit of patients and society.
Aiosyn combines science and engineering to transform top-tier research into leading AI-powered medical products from the heart of Europe.
It offers a flexible and interoperable AI platform to create biomarker solutions, ready to accommodate any size of workload at global scale, and supports CROs and biopharma with AI-powered solutions to identify novel pathology-based biomarkers that can accelerate drug development.